Clinical Study

Bone Marrow Stem Cells Added to a Hydroxyapatite Scaffold Result in Better Outcomes after Surgical Treatment of Intertrochanteric Hip Fractures

Figure 2

An X-Ray at 0 and 90 days of a patient from group A, showing higher density on the region where the ABMC/GRHC was added. ABMC: autologous bone marrow concentrate; GRHC: glass reinforced hydroxyapatite composite.
451781.fig.002a
(a)
451781.fig.002b
(b)